These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11398082

  • 1. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma.
    Krishna MT, Chauhan A, Little L, Sampson K, Hawksworth R, Mant T, Djukanovic R, Lee T, Holgate S.
    J Allergy Clin Immunol; 2001 Jun; 107(6):1039-45. PubMed ID: 11398082
    [Abstract] [Full Text] [Related]

  • 2. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW.
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [Abstract] [Full Text] [Related]

  • 3. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
    Diamant Z, Van der Veen H, Kuijpers EA, Bakker PF, Sterk PJ.
    Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
    [Abstract] [Full Text] [Related]

  • 4. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S.
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M, Bruce C, Sjöstrand M, Arvidsson P, Lötvall J.
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
    Ravensberg AJ, Luijk B, Westers P, Hiemstra PS, Sterk PJ, Lammers JW, Rabe KF.
    Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.
    Schaafsma D, Bos IS, Zuidhof AB, Zaagsma J, Meurs H.
    Respir Res; 2006 Sep 26; 7(1):121. PubMed ID: 17002806
    [Abstract] [Full Text] [Related]

  • 12. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM, Beier J, Meyer M, Buhl R, Zahlten R, Wolff G.
    Pulm Pharmacol Ther; 2006 Sep 26; 19(4):233-41. PubMed ID: 16140027
    [Abstract] [Full Text] [Related]

  • 13. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.
    Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, Warne RL, Moore WR, Tanaka RD.
    Am J Respir Crit Care Med; 1995 Dec 26; 152(6 Pt 1):2076-83. PubMed ID: 8520778
    [Abstract] [Full Text] [Related]

  • 14. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    van Schalkwyk E, Strydom K, Williams Z, Venter L, Leichtl S, Schmid-Wirlitsch C, Bredenbröker D, Bardin PG.
    J Allergy Clin Immunol; 2005 Aug 26; 116(2):292-8. PubMed ID: 16083782
    [Abstract] [Full Text] [Related]

  • 15. Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma.
    Jarjour NN, Lacouture PG, Busse WW.
    Ann Allergy Asthma Immunol; 1998 Sep 26; 81(3):231-6. PubMed ID: 9759799
    [Abstract] [Full Text] [Related]

  • 16. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
    Diamant Z, Kuperus J, Baan R, Nietzmann K, Millet S, Mendes P, Miller B, Amin D, Rohatagi S, Sterk PJ, Hoogsteden HC, Prins JB.
    Clin Exp Allergy; 2005 Aug 26; 35(8):1080-7. PubMed ID: 16120091
    [Abstract] [Full Text] [Related]

  • 17. Optimisation of the sensitisation conditions for an ovalbumin challenge model of asthma.
    Smith N, Broadley KJ.
    Int Immunopharmacol; 2007 Feb 26; 7(2):183-90. PubMed ID: 17178385
    [Abstract] [Full Text] [Related]

  • 18. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
    Subbarao P, Dorman SC, Rerecich T, Watson RM, Gauvreau GM, O'Byrne PM.
    J Allergy Clin Immunol; 2005 Apr 26; 115(4):745-50. PubMed ID: 15805993
    [Abstract] [Full Text] [Related]

  • 19. The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma.
    Duong M, Cockcroft D, Boulet LP, Ahmed T, Iverson H, Atkinson DC, Stahl EG, Watson R, Davis B, Milot J, Gauvreau GM, O'Byrne PM.
    Allergy; 2008 Sep 26; 63(9):1195-201. PubMed ID: 18699936
    [Abstract] [Full Text] [Related]

  • 20. Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response.
    Luijk B, van den Berge M, Kerstjens HA, Postma DS, Cass L, Sabin A, Lammers JW.
    Allergy; 2008 Jan 26; 63(1):75-80. PubMed ID: 17944983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.